The store will not work correctly when cookies are disabled.
(R)-2-(2-fluorophenyl)-3-phenyl-2,3-dihydroquinazolin-4(1H)-one
ID: ALA4092437
PubChem CID: 712064
Max Phase: Preclinical
Molecular Formula: C20H15FN2O
Molecular Weight: 318.35
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C1c2ccccc2N[C@@H](c2ccccc2F)N1c1ccccc1
Standard InChI: InChI=1S/C20H15FN2O/c21-17-12-6-4-10-15(17)19-22-18-13-7-5-11-16(18)20(24)23(19)14-8-2-1-3-9-14/h1-13,19,22H/t19-/m1/s1
Standard InChI Key: UMMDFHVNOCVOCD-LJQANCHMSA-N
Molfile:
RDKit 2D
24 27 0 0 0 0 0 0 0 0999 V2000
7.7371 -3.4338 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7360 -4.2534 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4440 -4.6623 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4422 -3.0250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1509 -3.4302 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1497 -4.2554 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8598 -4.6667 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.5756 -4.2575 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5768 -3.4323 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.8622 -3.0164 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8622 -2.1992 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.2855 -3.0254 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9908 -3.4400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6990 -3.0338 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7015 -2.2158 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9898 -1.8056 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2845 -2.2141 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2822 -4.6680 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2747 -5.4861 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9804 -5.8966 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6902 -5.4900 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6899 -4.6686 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9836 -4.2618 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5644 -5.8903 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
5 10 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
10 11 2 0
9 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
8 18 1 6
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
19 24 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 318.35 | Molecular Weight (Monoisotopic): 318.1168 | AlogP: 4.60 | #Rotatable Bonds: 2 |
Polar Surface Area: 32.34 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 11.87 | CX Basic pKa: ┄ | CX LogP: 5.07 | CX LogD: 5.07 |
Aromatic Rings: 3 | Heavy Atoms: 24 | QED Weighted: 0.75 | Np Likeness Score: -1.03 |
References
1. Jiang Y, Zhuang C, Chen L, Lu J, Dong G, Miao Z, Zhang W, Li J, Sheng C.. (2017) Structural Biology-Inspired Discovery of Novel KRAS-PDEδ Inhibitors., 60 (22): [PMID:28929751] [10.1021/acs.jmedchem.7b01243] |